Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 45,644 |
|
|||||
| News | - | ||||||
| Day High | 21.19 | Low High |
|||||
| Day Low | 20.50 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Prothena Corporation PLC | PRTA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.25 | -1.18% | 20.94 | 09:44:19 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 20.91 | 20.50 | 21.19 | 21.19 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,449 | 45,644 | US$ 20.96 | US$ 956,551 | - | 19.65 - 79.65 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:45:00 | 3 | US$ 20.95 | USD |
Prothena Corporation PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.13B | 53.72M | - | 91.37M | -147.03M | -2.74 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Prothena News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRTA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 21.25 | 22.09 | 19.65 | 20.78 | 450,348 | -0.31 | -1.46% |
| 1 Month | 25.02 | 25.3631 | 19.65 | 22.20 | 512,234 | -4.08 | -16.31% |
| 3 Months | 25.03 | 31.03 | 19.65 | 25.76 | 612,271 | -4.09 | -16.34% |
| 6 Months | 36.01 | 41.545 | 19.65 | 31.55 | 738,927 | -15.07 | -41.85% |
| 1 Year | 52.59 | 79.65 | 19.65 | 42.54 | 627,578 | -31.65 | -60.18% |
| 3 Years | 26.54 | 79.749 | 19.65 | 45.26 | 529,009 | -5.60 | -21.10% |
| 5 Years | 10.64 | 79.749 | 6.44 | 37.01 | 426,506 | 10.30 | 96.80% |
Prothena Description
| Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). |
